Suppr超能文献

不稳定型心绞痛中纤溶酶-α2抗纤溶酶复合物水平升高。

Elevated levels of plasmin-alpha2 antiplasmin complexes in unstable angina.

作者信息

Bayés-Genís A, Guindo J, Oliver A, Badimon L, Fiol M, Mateo J, Souto J C, Dominguez J M, Fontcuberta J, Bayés de Luna A

机构信息

Department of Cardiology, Hospital de Sant Pau, Barcelona, Spain.

出版信息

Thromb Haemost. 1999 Jun;81(6):865-8.

Abstract

The evidence of elevated levels of several biochemical markers of prothrombotic state in patients with unstable angina suggests that thrombus formation and lysis play a pivotal role in acute coronary syndromes. The clinical syndrome of unstable angina encompasses a variety of clinical presentations of transient episodes of myocardial ischemia. This study was designed to assess plasmin generation in different settings of unstable angina. Evidence of plasmin generation in patients with unstable angina was measured by circulating plasmin-alpha2 antiplasmin complexes (PAP). A second objective was to identify whether PAP levels had a prognostic value to predict outcome. Eighty-five patients admitted to the coronary care unit for unstable angina were classified into three groups. Group A included 26 patients with postinfarction angina; group B comprised 26 patients with new onset angina; and group C included 33 patients with crescendo angina. Mean PAP levels were higher in the three groups compared to healthy controls. A significant correlation was found between levels of PAP and D-dimer, particularly in postinfarction angina (r = 0.6; p <0.0005). This trial adds new insights into the pathophysiology of unstable angina. It demonstrates that plasmin is generated in the different settings of unstable angina but particularly in postinfarction angina patients where a fibrin-rich thrombus is responsible of the symptoms. However, in this series PAP levels do not predict an uneventful outcome neither in the acute phase nor at long term (6 months).

摘要

不稳定型心绞痛患者多种促血栓形成状态生化标志物水平升高的证据表明,血栓形成和溶解在急性冠脉综合征中起关键作用。不稳定型心绞痛的临床综合征包括心肌缺血短暂发作的多种临床表现。本研究旨在评估不稳定型心绞痛不同情况下的纤溶酶生成情况。通过循环纤溶酶-α2抗纤溶酶复合物(PAP)来检测不稳定型心绞痛患者纤溶酶生成的证据。第二个目标是确定PAP水平是否具有预测预后的价值。85例因不稳定型心绞痛入住冠心病监护病房的患者被分为三组。A组包括26例梗死后心绞痛患者;B组包括26例初发型心绞痛患者;C组包括33例恶化型心绞痛患者。与健康对照组相比,三组的平均PAP水平更高。发现PAP水平与D-二聚体之间存在显著相关性,尤其是在梗死后心绞痛患者中(r = 0.6;p <0.0005)。该试验为不稳定型心绞痛的病理生理学提供了新的见解。它表明在不稳定型心绞痛的不同情况下都会生成纤溶酶,但在梗死后心绞痛患者中尤为明显,此类患者症状由富含纤维蛋白的血栓所致。然而,在本系列研究中,PAP水平在急性期或长期(6个月)均不能预测良好的预后。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验